Pfizer Inc. (NYSE:PFE) shareholders are about to get a Botox injection as the U.S. pharma company is starting talks with Allergan Plc. (NYSE:AGN), one of the world’s top producers of cosmetic Botox. Holders of PFE stock know that a …
The stock rose 0.28% or $0.09 reaching $31.84. Pfizer Inc. (NYSE:PFE)'s stock has performed at -2.25%. It has underperformed by 0.72% the S&P500. LANKLER DOUGLAS M sold $693,200 worth of Pfizer Inc. (NYSE:WSM) is a …
As I look across the stock market, Pfizer Inc. (NYSE:PFE) looks like a great candidate to resume the year-to-date rally. Thus, to me, PFE stock offers additional upside than just its 3.8% dividend yield. Broadly speaking, stocks had a …
Pfizer stock certainly produced high yields from 2010 to 2015. Its share price more than doubled over the period. However, this growth can be attributed to the broader economic recovery following the Great Recession. Both the Dow Jones and …
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc (Symbol: PFE). So this week we highlight one interesting put contract, and one interesting call contract, from …
Pfizer Inc. (NYSE:PFE)‘s stock had its “buy” rating restated by stock analysts at Sanford C. Bernstein in a report issued on Monday, April 24th. They currently have a $35.00 price objective on the biopharmaceutical company’s stock. …
Woodley Farra Manion Portfolio Management Inc. now owns 106,653 shares of the biopharmaceutical company's stock worth $3,612,000 after buying an additional 284 shares in the last quarter. (NYSE:PFE). Icon Advisers holds 385,200 …
Linked here is a detailed quantitative analysis of Pfizer Inc. (PFE). Below are some highlights from the above linked analysis: Company Description: Pfizer Inc. ranks as one of the world's largest pharmaceutical companies, offering a …
The stock has "Neutral" rating by Suntrust Robinson on Wednesday, November 25. As per Monday, July 10, the company rating was maintained by Cowen & Co. Several research firms have recently issued reports on PFE. BidaskClub …
Pfizer (PFE-$33), among the world's largest and most reputable drug ... plus principal appreciation. And though the stock has been dead in the water for years, Wall Street (which owns nearly a billion shares) seems to believe it's time for this …